Cedarburg Hauser Pharmaceuticals (CHP) has expanded capacity at its Wisconsin-based API manufacturing plant and made additional upgrades aimed at improving safety and GMP systems.   “These improvements increase our total reactor capacity by nearly 50%,” said John Flahive, CHP’s director of operations. “We have also added a reactor and chiller that allow for cryogenic reactions in our GMP labs.”   In addition to new reactors, the company has made improvements to the air ha...